health

Antimicrobial Resistance – OECD

[ad_1]

 

Antimicrobial resistance (AMR) is a fancy problem of world concern with doubtlessly dramatic well being and financial penalties.

The OECD gives international locations with the proof to implement efficient and cost-effective One Well being insurance policies to deal with AMR, promote efficient use of antimicrobials in human and animal well being, strengthen an infection prevention and management measures, and incentivise analysis and growth within the antibiotic sector.

AMR-Stopping-Superbug-Tide

LATEST EVENT – HIGH-LEVEL ONE HEALTH MINISTERIAL CONFERENCE ON ANTIMICROBIAL RESISTANCE

AMR-ECDC-Policy-Brief-2022

Excessive-Stage One Well being Ministerial Assembly On Antimicrobial Resistance, French Presidency of the EU Council
Paris, France – March 7, 2022

The OECD, in collaboration with the European Centre for Illness Prevention and Management, the European Meals Security Authority and the European Medicines Company, has produced a briefing notice on antimicrobial resistance (AMR) within the European Union and European Financial Space. It presents tendencies in antibiotic consumption and AMR from a One Well being perspective, and units out coverage choices for nationwide governments and the European Union.

Key paperwork on antimicrobial resistance

G7 WORK ON AMR

The G7 has constantly dedicated to tackling world well being challenges, together with the battle towards infectious ailments, and positioned itself as a number one companion in reaching health-related Millennium Improvement Objectives, by initiating and supporting many world devices of response to threats posed by infectious ailments. The findings introduced on this report present that there’s a sturdy case for G7 motion within the space of AMR.

G20 WORK ON AMR

Learn the note prepared for the G20 by OECD together with WHO, FAO and OIE, on potential methods to deal with antimicrobial resistance (AMR) and guarantee sustainable analysis and growth (R&D) for brand new antibiotics. The notice requires motion based mostly on a coordinated and cross-sectoral strategy below the ‘One Well being’ framework, highlights the pressing want to deal with limitations to innovation and suggests coverage and governance mechanisms to reactivate the antibiotic R&D pipeline.

Within the Hamburg G20 declaration, leaders known as for a brand new R&D Collaboration Hub and dedicated to additional study sensible market incentive choices, in collaboration with related specialists together with from the OECD and the WHO.
 

FURTHER READING

CONTACT

For extra info, please contact health.contact@oecd.org

‌ Small follow us Twitter icon‌ 
Comply with us on Twitter @OECD_Social

 

 



[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button